The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene NFATC1 (also known as NFAT2 or NFATc) encodes the transcription factor NFATc1, a member of the calcium-responsive Nuclear Factor of Activated T-cells family in humans (UniProt: O95644) (cai2021roleofnfat pages 1-2). The protein domains identified in UniProt—Ig-like fold, Ig E-set, IPT domain, NFAT domain, and p53-like transcription factor DNA-binding superfamily—are consistent with NFATc1's characterized structural and functional properties as a Rel-family transcription factor regulated by calcium-dependent signaling (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 1-3).
NFATc1 exhibits a conserved domain architecture shared among calcium-regulated NFAT proteins (NFATc1–4). The protein consists of several functionally distinct regions described in detail below and summarized in the accompanying table.
| Domain name | Location / function | Key features | Regulatory significance |
|---|---|---|---|
| NFAT homology region (NHR; regulatory domain) | N-terminal regulatory region controlling phosphorylation, calcineurin docking, and nucleocytoplasmic trafficking | Contains serine-rich regions, Ser-Pro motifs, calcineurin-docking motifs, and an NLS; distinct from the DNA-binding domain | Multisite phosphorylation retains NFATc1 in the cytoplasm; calcineurin-mediated dephosphorylation produces the active nuclear form (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 1-3) |
| Rel homology region (RHR/RHD; DNA-binding domain) | Conserved central or distal region that contacts DNA | Rel/NF-κB-like DNA-binding fold; recognizes a core 5′-GGAA(A)-3′ motif; monomeric DNA binding is generally weak | Confers sequence recognition, while partners such as AP-1 stabilize binding and determine promoter and cell-context specificity (patterson2021transcriptionalregulationby pages 3-6) |
| Nuclear localization signal (NLS) | Embedded in or functionally coupled to the regulatory NHR; directs nuclear import | Accessibility is conformationally controlled by phosphorylation | Masked in phosphorylated NFATc1 in resting cells and exposed after calcineurin-mediated dephosphorylation, enabling cytoplasm-to-nucleus translocation (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 3-6) |
| N- and C-terminal transactivation domains (TADs) | Variable terminal regions that recruit transcriptional cofactors and modulate activation or repression | Less conserved than the NHR and RHR; alternative NFATC1 isoforms differ in terminal regions; the C-terminal TAD contributes to isoform-specific activity | Help determine target-gene output and cofactor selection; domain differences contribute to NFATc1-specific cytokine regulation and functional differences from NFATc2 (patterson2021transcriptionalregulationby pages 1-3, kitamura2021isoformselectivenfatinhibitor pages 5-7) |
| PxIxIT calcineurin-docking motif | Located in the NHR; provides a high-affinity docking interface for calcineurin | Conserved short linear motif; competitively recognized by the NFAT-inhibitory peptide VIVIT | Positions activated calcineurin to dephosphorylate NFATc1; disruption inhibits dephosphorylation, nuclear import, and NFAT-dependent transcription (oliveira2026calcineurinnfatsignalingin pages 6-9, thiel2021ca2+microdomainscalcineurin pages 10-12) |
| LxVP calcineurin-docking motif | Regulatory region; provides a second calcineurin-contact site | Conserved docking motif distinct from PxIxIT and associated with substrate recognition during active signaling | Cooperates with PxIxIT to support efficient, signal-dependent calcineurin engagement and NFATc1 activation (oliveira2026calcineurinnfatsignalingin pages 6-9, oliveira2026calcineurinnfatsignalingin pages 29-33) |
| Serine-rich regions and Ser-Pro phosphorylation motifs | Distributed through the NHR; form a phosphorylation-sensitive trafficking switch | Contain multiple regulatory phosphoserines, including SRR and SP clusters targeted by GSK3, CK1, DYRK1A, and other kinases | Phosphorylation favors cytoplasmic sequestration or nuclear export; calcineurin removes phosphates to expose the NLS, whereas rephosphorylation terminates signaling (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 3-6) |
| Composite transcription-factor interaction surfaces | Primarily within the RHR and variable TADs; mediate cooperative transcriptional complexes | Interact with AP-1 Fos/Jun and, depending on context, NF-κB, RUNX1, C/EBPα, BATF/IRF4, or other cofactors | Convert relatively weak NFATc1 DNA binding into stable, context-specific regulation; partner availability helps distinguish productive activation from AP-1-independent tolerance or exhaustion programs (patterson2021transcriptionalregulationby pages 3-6, samperebirlanga2026nonredundantfunctionsof pages 15-16) |
Table: Domain-level summary of human NFATc1, linking its conserved DNA-binding architecture and regulatory motifs to calcineurin-dependent trafficking and context-specific transcription.
The NFAT homology region (NHR) at the N-terminus serves as the principal regulatory domain (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 1-3). This region contains multiple serine-rich and serine-proline motifs that are extensively phosphorylated by kinases including GSK3, CK1, DYRK1A, and PKA in resting cells (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 3-6). The NHR also harbors two conserved calcineurin-docking motifs: PxIxIT and LxVP (oliveira2026calcineurinnfatsignalingin pages 6-9, oliveira2026calcineurinnfatsignalingin pages 29-33). These short linear sequences mediate high-affinity binding to the calcium-activated phosphatase calcineurin, positioning it to dephosphorylate the regulatory serines. Embedded within or functionally coupled to the NHR is a nuclear localization signal (NLS) whose accessibility is controlled by the phosphorylation state—phosphorylation masks the NLS and retains NFATc1 in the cytoplasm, while dephosphorylation exposes it and permits nuclear import (oliveira2026calcineurinnfatsignalingin pages 6-9, hui2023howdoesnfat3 pages 1-2).
The Rel homology region (RHR), also called the Rel homology domain or DNA-binding domain, represents the conserved central region responsible for DNA recognition (cai2021roleofnfat pages 1-2, oliveira2026calcineurinnfatsignalingin pages 6-9). This domain shares structural homology with the Rel/NF-κB transcription factor superfamily and recognizes a core consensus DNA sequence of 5′-GGAA(A)-3′ (patterson2021transcriptionalregulationby pages 3-6, patterson2021transcriptionalregulationby pages 6-8). However, NFATc1's DNA binding as a monomer is relatively weak, and effective transcriptional regulation generally requires cooperative binding with partner transcription factors at composite regulatory elements (patterson2021transcriptionalregulationby pages 3-6).
Variable N- and C-terminal transactivation domains (TADs) flank the conserved core regions (patterson2021transcriptionalregulationby pages 1-3). These less-conserved terminal regions recruit transcriptional cofactors and modulate gene activation or repression. Alternative splicing and promoter usage generate NFATc1 isoforms with distinct terminal sequences, contributing to functional specialization; notably, the C-terminal TAD has been shown to contribute to NFATc1-specific cytokine regulation (kitamura2021isoformselectivenfatinhibitor pages 5-7).
NFATc1 recognizes the consensus DNA motif 5′-GGAA(A)-3′ through its Rel homology domain (patterson2021transcriptionalregulationby pages 3-6, patterson2021transcriptionalregulationby pages 6-8). Because monomeric NFAT–DNA binding is weak, productive transcriptional regulation depends on cooperative interactions with other transcription factors, most notably the AP-1 family proteins Fos and Jun, which bind adjacent sites at composite NFAT/AP-1 elements (patterson2021transcriptionalregulationby pages 3-6, kitamura2021isoformselectivenfatinhibitor pages 5-7). Depending on cellular context and promoter architecture, NFATc1 also cooperates with NF-κB, RUNX1, C/EBPα, BATF, IRF4, and other factors to achieve target-gene specificity (patterson2021transcriptionalregulationby pages 3-6, samperebirlanga2026nonredundantfunctionsof pages 15-16).
Identified direct or regulated target genes of NFATc1 include cytokine genes (IL-2, IL-4, IL-9, GM-CSF), metabolic regulators in pancreatic β-cells (HNF4A, CDC123, HHEX, GLIS3, SLC30A8, GIPR, MACF1), angiogenesis-related genes (VEGF, COX-2, CXCR7), and cell-cycle regulators (CDK4, cyclin, c-MYC) (patterson2021transcriptionalregulationby pages 6-8, kitamura2021isoformselectivenfatinhibitor pages 5-7, simonett2021identificationofdirect pages 4-5, kitamura2021isoformselectivenfatinhibitor pages 3-4, kitamura2021isoformselectivenfatinhibitor pages 9-10). In osteoclasts, NFATc1 regulates a master differentiation program including genes for osteoclast fusion, cytoskeletal organization, and matrix resorption (zheng2024recentadvancesof pages 1-3, zheng2024recentadvancesof pages 5-6). The transcription factor TOX, which drives T-cell exhaustion, is also induced by NFATc1 during chronic stimulation (samperebirlanga2026nonredundantfunctionsof pages 1-2, wu2024newopportunitiesto pages 4-6).
In resting or unstimulated cells, NFATc1 is highly phosphorylated on serine residues within the regulatory NHR and is retained in the cytoplasm (cai2021roleofnfat pages 1-2, patterson2021transcriptionalregulationby pages 3-6). This phosphorylation masks or inactivates the nuclear localization signal, preventing nuclear entry and maintaining the transcription factor in an inactive state (oliveira2026calcineurinnfatsignalingin pages 6-9, hui2023howdoesnfat3 pages 1-2).
Cell activation triggers an increase in intracellular calcium through calcium influx via plasma membrane channels (including store-operated calcium entry through Orai channels) or release from intracellular stores (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 3-6). Elevated Ca²⁺ binds to calmodulin (CaM), and the Ca²⁺/CaM complex associates with and activates the serine/threonine phosphatase calcineurin. Calcineurin is composed of a catalytic CnA subunit and a regulatory CnB subunit; Ca²⁺ binding to CnB and Ca²⁺/CaM binding to CnA displace the autoinhibitory domain, exposing the active site (oliveira2026calcineurinnfatsignalingin pages 6-9, oliveira2026calcineurinnfatsignalingin pages 29-33).
Activated calcineurin docks onto NFATc1 through the conserved PxIxIT and LxVP motifs and dephosphorylates the multiple regulatory serine residues in the NHR (oliveira2026calcineurinnfatsignalingin pages 6-9, thiel2021ca2+microdomainscalcineurin pages 10-12, oliveira2026calcineurinnfatsignalingin pages 29-33). This dephosphorylation induces a conformational change that exposes the nuclear localization signal, allowing nuclear import machinery to translocate NFATc1 from the cytoplasm into the nucleus (oliveira2026calcineurinnfatsignalingin pages 6-9, cai2021roleofnfat pages 1-2, thiel2021ca2+microdomainscalcineurin pages 10-12, thiel2021ca2+microdomainscalcineurin pages 17-18). Once in the nucleus, NFATc1 can bind DNA and cooperate with other transcription factors to regulate gene expression (cai2021roleofnfat pages 1-2).
Nuclear translocation is reversible. Constitutively active kinases, including GSK3β, CK1, DYRK1A, and JNK, rephosphorylate NFATc1, which masks the NLS and promotes nuclear export, returning the transcription factor to the cytoplasm when calcium signals decline (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 3-6). The balance between calcineurin-mediated dephosphorylation and kinase-mediated rephosphorylation thus determines NFATc1 localization and transcriptional activity (oliveira2026calcineurinnfatsignalingin pages 6-9, thiel2021ca2+microdomainscalcineurin pages 10-12). This dynamic equilibrium allows NFAT signaling to decode the duration and amplitude of calcium signals, with sustained Ca²⁺ elevation and nuclear calcineurin activity required for prolonged transcriptional responses (oliveira2026calcineurinnfatsignalingin pages 6-9, thiel2021ca2+microdomainscalcineurin pages 10-12).
The primary signaling pathway regulating NFATc1 is the calcium-calcineurin-NFAT axis. Receptor stimulation (e.g., T-cell receptor, receptor tyrosine kinases, or G-protein-coupled receptors) activates phospholipase C (PLC), which generates IP₃ and triggers store-operated calcium entry (SOCE), raising cytoplasmic Ca²⁺ (patterson2021transcriptionalregulationby pages 3-6). The Ca²⁺/calmodulin-activated phosphatase calcineurin then dephosphorylates NFATc1, enabling its nuclear translocation and transcriptional activity (oliveira2026calcineurinnfatsignalingin pages 6-9, cai2021roleofnfat pages 1-2, thiel2021ca2+microdomainscalcineurin pages 10-12, patterson2021transcriptionalregulationby pages 3-6).
Multiple kinases oppose calcineurin by phosphorylating NFATc1 and promoting its cytoplasmic retention or nuclear export. Key regulatory kinases include:
- GSK3 (Glycogen synthase kinase 3): Phosphorylates serine-rich regions, masking the NLS (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 3-6)
- CK1 (Casein kinase 1): Contributes to the phosphorylation code controlling localization (oliveira2026calcineurinnfatsignalingin pages 6-9, patterson2021transcriptionalregulationby pages 3-6)
- DYRK1A: Phosphorylates the regulatory domain (oliveira2026calcineurinnfatsignalingin pages 6-9)
- JNK (c-Jun N-terminal kinase): Linked to stress and inflammatory pathways and can phosphorylate NFATc1 (patterson2021transcriptionalregulationby pages 3-6, cai2021roleofnfat pages 1-2)
- p38 MAPK: Provides additional nuclear regulation by phosphorylating distinct sites that influence transactivation (patterson2021transcriptionalregulationby pages 3-6)
Because NFATc1's intrinsic DNA-binding affinity is modest, its transcriptional output depends critically on protein-protein interactions with cooperating transcription factors:
NFATc1 activity is modulated by additional signaling pathways beyond direct Ca²⁺/calcineurin regulation:
- CD137-CD137L signaling: Activates a TRAF6→JNK→AP-1 cascade that cooperates with NFATc1 (cai2021roleofnfat pages 1-2)
- OX40-OX40L signaling: Regulates NFATc1 in lymphocytes (cai2021roleofnfat pages 1-2)
- RANKL-RANK-TRAF6: In osteoclasts, this pathway activates NF-κB and MAPK cascades that converge on NFATc1 to drive osteoclastogenesis (zheng2024recentadvancesof pages 1-3, zheng2024recentadvancesof pages 5-6)
NFATc1 participates in diverse biological processes across multiple organ systems. A comprehensive summary of these functions, including recent findings from 2023–2026, is provided below.
| Biological process / system | Specific function | Mechanism | Key evidence / recent findings |
|---|---|---|---|
| T-cell activation and clonal expansion | Converts antigen-receptor–evoked Ca²⁺ signals into transcription supporting proliferation, survival, and effector function | TCR signaling drives Ca²⁺ entry; Ca²⁺/calmodulin activates calcineurin, which dephosphorylates NFATc1 and enables nuclear import. Nuclear NFATc1 binds GGAA(A)-containing elements, often cooperatively with AP-1; inducible NFATc1/αA also positively autoregulates NFATC1 expression | NFATc1 loss impairs antigen-driven lymphocyte expansion and effector responses. A 2024 mouse study found that NFATc1-deficient CD8⁺ cells failed to sustain inflationary memory responses during latent cytomegalovirus infection (yang2025nfatc1incd4+ pages 1-2, patterson2021transcriptionalregulationby pages 3-6, chaudhry2024nfatsignalingis pages 7-9) |
| CD4⁺ T-helper differentiation and type-2 immunity | Promotes TH2 differentiation and production of type-2 cytokines, especially IL-4; contributes to allergic inflammation | NFATc1 cooperates with AP-1 and promoter-specific cofactors to regulate cytokine genes; its transcriptional effects differ from those of NFATc2 | Conditional Nfatc1 deficiency in CD4⁺ T cells reduced TH2 polarization, IgE, mast-cell accumulation, and eosinophilic lung inflammation in an allergic-asthma model reported online in 2024 and published in 2025 (kitamura2021isoformselectivenfatinhibitor pages 5-7, yang2025nfatc1incd4+ pages 1-2) |
| Dendritic-cell–T-cell communication | Supports dendritic-cell priming of T-cell proliferation and subsequent TH2 differentiation | NFATc1-dependent transcription in CD11c⁺ antigen-presenting cells helps establish an effective priming environment | Deleting Nfatc1 in CD11c⁺ cells weakened T-cell priming, proliferation, and TH2 responses in experimental allergic asthma (yang2025nfatc1incd4+ pages 1-2) |
| Persistent CD8⁺ memory responses | Maintains antigen-specific effector-memory and inflationary CD8⁺ populations during persistent infection | Recurrent antigen signaling sustains NFAT-dependent maturation and survival programs rather than being strictly required for initial priming | A 2024 MCMV study found largely preserved acute responses but defective long-term inflation after NFATc1 deletion; combined NFATc1/NFATc2 loss caused the strongest defects and impaired adoptive control of CMV (chaudhry2024nfatsignalingis pages 7-9) |
| CD8⁺ T-cell chronic stimulation and exhaustion | Inducible NFATc1/αA primarily supports survival and persistence of progenitor-exhausted and exhausted cells; NFATc2 has a stronger role in terminal dysfunction | Chronic TCR signaling induces the P1-promoter-derived NFATc1/αA isoform, promotes TOX expression, limits NFATc2, and shifts the Bim/BCL-2 survival balance; some outputs can occur without AP-1 | In chronic LCMV models, Nfatc1a RNA increased approximately 10–20-fold in progenitor and terminally exhausted cells. NFATc1-deficient virus-specific cells became nearly undetectable by day 15, while enhancer deletion selectively removing inducible α isoforms impaired survival under chronic stimulation (samperebirlanga2026nonredundantfunctionsof pages 4-5, samperebirlanga2026nonredundantfunctionsof pages 1-2, samperebirlanga2026nonredundantfunctionsof pages 12-13, samperebirlanga2026nonredundantfunctionsof pages 5-7, samperebirlanga2026nonredundantfunctionsof pages 7-8) |
| Osteoclast differentiation and bone resorption | Acts as a master transcriptional regulator of osteoclast formation, fusion, maturation, cytoskeletal organization, and matrix resorption | RANKL–RANK recruits TRAF6 and activates NF-κB/MAPK pathways; immunoreceptor-associated Ca²⁺ signals activate calcineurin–NFATc1. NFATc1 then induces the osteoclast program and is restrained by BCL6, IRF8, MAFB, and LHX2 | A highly cited 2024 review synthesizes evidence that excessive NFATc1 activation drives rheumatoid-arthritis bone erosion and identifies the RANKL–RANK–TRAF6–NF-κB/MAPK–NFATc1 axis as a therapeutic intervention point (zheng2024recentadvancesof pages 1-3, zheng2024recentadvancesof pages 5-6) |
| Cardiovascular and valvular development | Required for normal endocardial, heart-valve, septal, and vascular development | Developmental Ca²⁺/calcineurin signaling activates NFATc1-dependent transcription in cardiovascular progenitor and endothelial contexts | Genetic loss in mice causes embryonic lethality associated with cardiovascular defects and organ hypoplasia, indicating a nonredundant developmental role (kitamura2021isoformselectivenfatinhibitor pages 4-5, kitamura2021isoformselectivenfatinhibitor pages 1-3) |
| Vascular remodeling and atherosclerosis | Regulates vascular smooth-muscle proliferation and phenotypic change, endothelial responses, inflammation, angiogenesis, foam-cell formation, and calcification | Calcineurin-dependent nuclear NFATc1 integrates Ca²⁺ signaling with CD137–TRAF6–JNK–AP-1 and OX40 pathways to alter vascular gene expression | Reviews link abnormal NFATc1 signaling to several stages of diabetic atherosclerosis, although much of the evidence is pathway- or family-level rather than uniquely isoform-specific (cai2021roleofnfat pages 1-2) |
| Pancreatic ductal adenocarcinoma | Supports oncogenic transcription, malignant progression, and interactions with epigenetic regulators | Ca²⁺/calcineurin–NFATc1 can activate MYC; NFATc1 also activates EZH2 transcription and forms a phosphorylation-dependent NFATc1–EZH2 complex | NFATc1 and EZH2 rose from metaplastic and premalignant lesions to established PDAC; human tumors showed a positive NFATC1–EZH2 mRNA correlation of r = 0.75, and abundant EZH2 occurred in 70% of specimens with high nuclear epithelial NFATc1 (kitamura2021isoformselectivenfatinhibitor pages 10-11, patil2021chromatinindependentinterplayof pages 5-6) |
| Other solid tumors | Can promote angiogenesis, epithelial–mesenchymal transition, invasion, and metastasis, but effects are tumor-context dependent | Reported targets and outputs include VEGF, COX-2, CXCR7, and SNAI1; NFATc1 may also regulate methylation-sensitive promoters | NFATc1 has been linked to colorectal-cancer EMT and metastasis and prostate-cancer growth and invasion, whereas pro-apoptotic FasL regulation suggests tumor-suppressive activity in hepatocellular carcinoma. These opposing observations argue against treating NFATc1 as uniformly oncogenic (kitamura2021isoformselectivenfatinhibitor pages 3-4, sato2024calcineurinnfatc1pathwayrepresses pages 11-12) |
| Hematologic malignancy and drug resistance | Promotes leukemic maintenance, dedifferentiation, and resistance in selected molecular contexts | Constitutively active NFATc1 cooperates with FLT3-ITD; NFAT-dependent autocrine IL-4 signaling can support kinase-inhibitor resistance | NFATc1 accelerated FLT3-ITD AML in experimental models; depletion or inhibition increased sorafenib sensitivity, while nuclear NFATc1 increased resistance. NFATc1-mediated IL-4 signaling has also been linked to imatinib resistance in CML (kitamura2021isoformselectivenfatinhibitor pages 10-11, patterson2021transcriptionalregulationby pages 8-9) |
| Histone homeostasis and genome stability | Represses histone-gene transcription, limiting potentially toxic histone accumulation | Ca²⁺/calcineurin activates NFATc1, which binds promoter regions of multiple histone genes and suppresses transcription | A 2024 study found that calcineurin inhibition increased histone abundance, whereas NFATc1 repressed histone H3 genes; excess H3 inhibited cell proliferation, suggesting a homeostatic role for the pathway (sato2024calcineurinnfatc1pathwayrepresses pages 11-12) |
| Human pancreatic β-cell biology | Regulates genes associated with β-cell proliferation, identity, and diabetes susceptibility | Nuclear NFATc1 binds or influences accessible enhancer/promoter programs with context-dependent transcriptional partners | In human islets, NFATC1 regulated HNF4A, CDC123, HHEX, GLIS3, and SLC30A8 together with NFATC2, while GIPR and MACF1 were reported as NFATC1-selective; direct binding was more extensively mapped for NFATC2, so NFATC1 directness remains less certain (simonett2021identificationofdirect pages 4-5) |
Table: This table links NFATc1’s principal physiological and pathological roles to their underlying signaling mechanisms and supporting evidence. It emphasizes recent findings in immunity, exhaustion, bone biology, cancer, and transcriptional homeostasis while distinguishing isoform-specific evidence from broader NFAT-family inference.
NFATc1 plays a central role in converting T-cell receptor (TCR)-evoked calcium signals into transcriptional programs supporting T-cell activation, clonal expansion, and effector function (yang2025nfatc1incd4+ pages 1-2, patterson2021transcriptionalregulationby pages 3-6). In CD4⁺ T cells, NFATc1 is particularly important for TH2 differentiation and the production of type-2 cytokines, especially IL-4 (kitamura2021isoformselectivenfatinhibitor pages 5-7, yang2025nfatc1incd4+ pages 1-2). A 2025 study demonstrated that conditional deletion of Nfatc1 in CD4⁺ T cells impaired TH2 polarization and reduced eosinophilic lung inflammation, IgE production, and mast-cell accumulation in an allergic asthma model (yang2025nfatc1incd4+ pages 1-2). The inducible NFATc1/αA isoform, generated from the P1 promoter, undergoes positive autoregulation and is preferentially expressed after initial and repeated T-cell stimulation, promoting antigen-driven proliferation and survival (yang2025nfatc1incd4+ pages 1-2, samperebirlanga2026nonredundantfunctionsof pages 1-2).
NFATc1 also functions in dendritic cells (DCs), where it supports the priming of T-cell responses. Deletion of Nfatc1 in CD11c⁺ DCs weakened T-cell priming, proliferation, and subsequent TH2 differentiation in experimental asthma (yang2025nfatc1incd4+ pages 1-2).
Recent research (2024–2026) has revealed a specialized role for the NFATc1/αA isoform in CD8⁺ T-cell exhaustion during chronic antigen stimulation. Unlike the constitutive isoforms, NFATc1/αA is strongly induced by persistent TCR signaling in the context of chronic infection or tumor-antigen exposure (samperebirlanga2026nonredundantfunctionsof pages 4-5, samperebirlanga2026nonredundantfunctionsof pages 1-2, samperebirlanga2026nonredundantfunctionsof pages 12-13). In chronic LCMV infection models, Nfatc1a RNA (encoding NFATc1/αA) increased 10–20-fold in both progenitor-exhausted (T_PEX) and terminally exhausted (T_EX) CD8⁺ T cells compared to resting cells (samperebirlanga2026nonredundantfunctionsof pages 4-5, samperebirlanga2026nonredundantfunctionsof pages 5-7). This isoform predominantly localizes to the nucleus after six days of chronic stimulation but is minimally induced by acute stimulation (samperebirlanga2026nonredundantfunctionsof pages 12-13).
Functionally, NFATc1/αA primarily supports the survival and persistence of exhausted T cells rather than driving terminal exhaustion directly (samperebirlanga2026nonredundantfunctionsof pages 1-2, samperebirlanga2026nonredundantfunctionsof pages 13-15, samperebirlanga2026nonredundantfunctionsof pages 7-8). NFATc1-deficient virus-specific CD8⁺ T cells failed to sustain long-term responses during chronic LCMV infection, becoming nearly undetectable by day 15 post-infection, whereas acute responses were largely preserved (samperebirlanga2026nonredundantfunctionsof pages 5-7, samperebirlanga2026nonredundantfunctionsof pages 7-8, chaudhry2024nfatsignalingis pages 7-9). NFATc1/αA supports survival partly by repressing the pro-apoptotic protein Bim and maintaining a favorable Bim/BCL-2 balance (samperebirlanga2026nonredundantfunctionsof pages 13-15, samperebirlanga2026nonredundantfunctionsof pages 7-8). It also induces the transcription factor TOX, which orchestrates the exhaustion program, but NFATc1's primary contribution appears to be sustaining exhausted cells in a progenitor-like state rather than promoting terminal dysfunction—a role more strongly associated with NFATc2 (samperebirlanga2026nonredundantfunctionsof pages 1-2, samperebirlanga2026nonredundantfunctionsof pages 13-15, samperebirlanga2026nonredundantfunctionsof pages 5-7, samperebirlanga2026nonredundantfunctionsof pages 7-8). These findings have implications for improving CAR T-cell and checkpoint-blockade immunotherapies (samperebirlanga2026nonredundantfunctionsof pages 1-2).
A 2024 MCMV study corroborated NFATc1's role in persistent CD8⁺ memory responses, showing that NFATc1 is essential for maintaining inflationary effector-memory populations during latent cytomegalovirus infection, even though acute infection control is largely preserved (chaudhry2024nfatsignalingis pages 7-9).
NFATc1 is recognized as a master transcriptional regulator of osteoclastogenesis (zheng2024recentadvancesof pages 1-3, zheng2024recentadvancesof pages 5-6). Following RANKL binding to RANK on osteoclast precursor cells, TRAF6 activates NF-κB and MAPK pathways while calcium-dependent co-stimulatory signals (e.g., from immunoreceptors) activate calcineurin, which dephosphorylates and activates NFATc1. Nuclear NFATc1 then drives the transcription of osteoclast-specific genes required for differentiation, fusion, maturation, cytoskeletal reorganization (F-actin ring formation), and the degradation of organic and inorganic bone matrix components (zheng2024recentadvancesof pages 1-3, zheng2024recentadvancesof pages 5-6). Inhibitory regulators such as BCL6, IRF8, MAFB, and LHX2 restrain NFATc1 activity under physiological conditions.
In pathological contexts such as rheumatoid arthritis, excessive NFATc1 activation—driven by increased RANKL and inflammatory cytokines from synovial fibroblasts and immune cells—promotes abnormal osteoclast formation and bone destruction (zheng2024recentadvancesof pages 1-3, zheng2024recentadvancesof pages 5-6). A highly cited 2024 review identifies the RANKL–RANK–TRAF6–NF-κB/MAPK–NFATc1 axis as a key therapeutic target for RA-associated bone loss (zheng2024recentadvancesof pages 1-3).
NFATc1 is essential for normal cardiovascular development. It is required for endocardial, heart valve, septal, and vascular formation during embryogenesis (kitamura2021isoformselectivenfatinhibitor pages 4-5, kitamura2021isoformselectivenfatinhibitor pages 1-3). Genetic loss of NFATc1 in mice results in embryonic lethality due to cardiovascular defects and organ hypoplasia, demonstrating a nonredundant developmental role (kitamura2021isoformselectivenfatinhibitor pages 1-3, kitamura2021isoformselectivenfatinhibitor pages 4-5).
In adults, NFATc1 also participates in vascular remodeling processes, including vascular smooth muscle cell proliferation and phenotypic transition, endothelial responses, inflammation, angiogenesis, macrophage foam-cell formation, and vascular calcification (cai2021roleofnfat pages 1-2). NFATc1 has been implicated in the pathogenesis of diabetic atherosclerosis, where it integrates CD137–TRAF6–JNK–AP-1 and OX40 signaling pathways to alter vascular gene expression (cai2021roleofnfat pages 1-2).
NFATc1's role in cancer is context-dependent and varies by tumor type. In pancreatic ductal adenocarcinoma (PDAC), NFATc1 supports oncogenic transcription and malignant progression (kitamura2021isoformselectivenfatinhibitor pages 10-11, patil2021chromatinindependentinterplayof pages 5-6, kitamura2021isoformselectivenfatinhibitor pages 3-4). Ectopic Ca²⁺/calcineurin–NFATc1 activation promotes MYC overexpression, a key oncogenic driver (kitamura2021isoformselectivenfatinhibitor pages 10-11, sato2024calcineurinnfatc1pathwayrepresses pages 11-12). A 2021 study found that NFATc1 directly activates transcription of the epigenetic regulator EZH2, and the two proteins form a phosphorylation-dependent complex. NFATc1 and EZH2 expression increased progressively from acinar-to-ductal metaplasia through PanIN lesions to established PDAC in mouse models. In human PDAC specimens, 70% with high epithelial nuclear NFATc1 also showed abundant EZH2, and mRNA levels were positively correlated (r = 0.75) (patil2021chromatinindependentinterplayof pages 5-6).
In colorectal cancer, NFATc1 promotes epithelial–mesenchymal transition, metastasis, and poor prognosis by targeting SNAI1 and other genes (sato2024calcineurinnfatc1pathwayrepresses pages 11-12, kitamura2021isoformselectivenfatinhibitor pages 3-4). In prostate cancer, calcineurin inhibitors suppress proliferation, migration, and invasion, implicating the calcineurin–NFATc1 pathway in progression (sato2024calcineurinnfatc1pathwayrepresses pages 11-12). Conversely, in hepatocellular carcinoma, NFATc1 acts as a tumor suppressor by promoting apoptosis through FasL-mediated signaling (sato2024calcineurinnfatc1pathwayrepresses pages 11-12), illustrating that NFATc1's effects are not uniformly oncogenic.
In hematologic malignancies, constitutively active NFATc1 cooperates with FLT3-ITD (internal tandem duplication) mutations to accelerate acute myeloid leukemia (AML) development and expand immature blasts (kitamura2021isoformselectivenfatinhibitor pages 10-11, patterson2021transcriptionalregulationby pages 8-9). NFATc1 depletion or pharmacologic inhibition with cyclosporin A or VIVIT increases sorafenib sensitivity in FLT3-ITD AML, while nuclear NFATc1 confers sorafenib resistance and promotes dedifferentiation (patterson2021transcriptionalregulationby pages 8-9). NFATc1-mediated autocrine IL-4 signaling has also been linked to imatinib resistance in chronic myeloid leukemia (patterson2021transcriptionalregulationby pages 8-9).
NFATc1 additionally promotes angiogenesis and lymphangiogenesis through induction of VEGF, COX-2, and CXCR7, processes associated with cancer infiltration and metastasis (kitamura2021isoformselectivenfatinhibitor pages 3-4, kitamura2021isoformselectivenfatinhibitor pages 10-11).
A 2024 study revealed a novel role for the calcineurin/NFATc1 pathway in histone homeostasis: NFATc1 binds to the promoters of multiple histone genes and represses histone H3 transcription, limiting potentially cytotoxic histone accumulation. Calcineurin inhibition increased histone levels, and excess histone H3 inhibited cell proliferation, suggesting a protective homeostatic function (sato2024calcineurinnfatc1pathwayrepresses pages 11-12).
In pancreatic β-cells, NFATc1 regulates genes associated with β-cell proliferation, identity, and diabetes susceptibility. In human islets, NFATc1 influenced expression of HNF4A, CDC123, HHEX, GLIS3, SLC30A8, GIPR, and MACF1, with some genes regulated specifically by NFATc1 (simonett2021identificationofdirect pages 4-5).
NFATc1 is a validated therapeutic target. The immunosuppressants cyclosporine A and tacrolimus inhibit calcineurin, preventing NFATc1 dephosphorylation and nuclear translocation, thereby suppressing NFAT-dependent cytokine transcription (patterson2021transcriptionalregulationby pages 3-6, patterson2021transcriptionalregulationby pages 8-9). However, these agents affect more than 50 calcineurin substrates and cause broad side effects (kitamura2021isoformselectivenfatinhibitor pages 4-5). More selective NFAT inhibitors have been developed:
- VIVIT: A peptide that selectively disrupts calcineurin docking to NFAT by competing for the PxIxIT binding site (patterson2021transcriptionalregulationby pages 3-6, thiel2021ca2+microdomainscalcineurin pages 10-12, patterson2021transcriptionalregulationby pages 8-9)
- A-285222 and INCA-6: Small-molecule direct NFAT inhibitors (kitamura2021isoformselectivenfatinhibitor pages 4-5)
NFATc1 (NFATC1 gene, UniProt O95644) is a calcium-responsive transcription factor with diverse and context-dependent functions across immune regulation, bone metabolism, cardiovascular development, and cancer biology. Its activity is tightly controlled by a dynamic interplay between calcium-activated calcineurin (which dephosphorylates and activates NFATc1) and multiple kinases (which rephosphorylate and inactivate it), translating transient calcium signals into sustained transcriptional programs. NFATc1 cooperates with partner transcription factors, particularly AP-1, to achieve target-gene specificity.
Recent findings (2023–2026) have highlighted the specialized role of the inducible NFATc1/αA isoform in supporting survival of exhausted CD8⁺ T cells during chronic stimulation, with implications for cancer immunotherapy. Additionally, NFATc1 continues to be recognized as a master regulator of osteoclastogenesis and a key target for treating rheumatoid arthritis–associated bone destruction. Its context-dependent functions in cancer—acting as an oncogenic driver in some tumor types but a tumor suppressor in others—underscore the complexity of NFAT biology and the need for careful therapeutic targeting strategies.
References
(cai2021roleofnfat pages 1-2): Yaoyao Cai, Haipeng Yao, Zhen Sun, Ying Wang, Yunyun Zhao, Zhongqun Wang, and Lihua Li. Role of nfat in the progression of diabetic atherosclerosis. Frontiers in Cardiovascular Medicine, Mar 2021. URL: https://doi.org/10.3389/fcvm.2021.635172, doi:10.3389/fcvm.2021.635172. This article has 35 citations and is from a peer-reviewed journal.
(oliveira2026calcineurinnfatsignalingin pages 6-9): Bruna Da Silva Oliveira, Metello Innocenti, and Francesca Granucci. Calcineurin/nfat signaling in the temporal integration of ca²⁺ stress in neurodegeneration. Cell Death Discovery, Jul 2026. URL: https://doi.org/10.1038/s41420-026-03251-3, doi:10.1038/s41420-026-03251-3. This article has 0 citations and is from a peer-reviewed journal.
(patterson2021transcriptionalregulationby pages 1-3): Shaun D. Patterson, Xu Huang, Heather G. Jørgensen, and Alison M. Michie. Transcriptional regulation by the nfat family in acute myeloid leukaemia. Hemato, 2:556-571, Aug 2021. URL: https://doi.org/10.3390/hemato2030035, doi:10.3390/hemato2030035. This article has 10 citations.
(patterson2021transcriptionalregulationby pages 3-6): Shaun D. Patterson, Xu Huang, Heather G. Jørgensen, and Alison M. Michie. Transcriptional regulation by the nfat family in acute myeloid leukaemia. Hemato, 2:556-571, Aug 2021. URL: https://doi.org/10.3390/hemato2030035, doi:10.3390/hemato2030035. This article has 10 citations.
(kitamura2021isoformselectivenfatinhibitor pages 5-7): Noriko Kitamura and Osamu Kaminuma. Isoform-selective nfat inhibitor: potential usefulness and development. International Journal of Molecular Sciences, 22:2725, Mar 2021. URL: https://doi.org/10.3390/ijms22052725, doi:10.3390/ijms22052725. This article has 35 citations.
(thiel2021ca2+microdomainscalcineurin pages 10-12): Gerald Thiel, Tobias Schmidt, and Oliver G. Rössler. Ca2+ microdomains, calcineurin and the regulation of gene transcription. Cells, 10:875, Apr 2021. URL: https://doi.org/10.3390/cells10040875, doi:10.3390/cells10040875. This article has 77 citations.
(oliveira2026calcineurinnfatsignalingin pages 29-33): Bruna Da Silva Oliveira, Metello Innocenti, and Francesca Granucci. Calcineurin/nfat signaling in the temporal integration of ca²⁺ stress in neurodegeneration. Cell Death Discovery, Jul 2026. URL: https://doi.org/10.1038/s41420-026-03251-3, doi:10.1038/s41420-026-03251-3. This article has 0 citations and is from a peer-reviewed journal.
(samperebirlanga2026nonredundantfunctionsof pages 15-16): Salvador Sampere-Birlanga, Stefan Klein-Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, and Friederike Berberich-Siebelt. Non-redundant functions of nfatc1 in survival and nfatc2 in generation of exhausted cd8+ t cells. Frontiers in Immunology, Jul 2026. URL: https://doi.org/10.3389/fimmu.2026.1869029, doi:10.3389/fimmu.2026.1869029. This article has 1 citations and is from a peer-reviewed journal.
(hui2023howdoesnfat3 pages 1-2): Wang Hui, Su Wenhua, Zhang Shuojie, Wang Lulin, Zhao Panpan, Zhang Tongtong, Xie Xiaoli, and Dan Juhua. How does nfat3 regulate the occurrence of cardiac hypertrophy? Oct 2023. URL: https://doi.org/10.1016/j.ijcha.2023.101271, doi:10.1016/j.ijcha.2023.101271. This article has 8 citations.
(patterson2021transcriptionalregulationby pages 6-8): Shaun D. Patterson, Xu Huang, Heather G. Jørgensen, and Alison M. Michie. Transcriptional regulation by the nfat family in acute myeloid leukaemia. Hemato, 2:556-571, Aug 2021. URL: https://doi.org/10.3390/hemato2030035, doi:10.3390/hemato2030035. This article has 10 citations.
(simonett2021identificationofdirect pages 4-5): Shane P. Simonett, Sunyoung Shin, Jacob A. Herring, Rhonda Bacher, Linsin A. Smith, Chenyang Dong, Mary E. Rabaglia, Donnie S. Stapleton, Kathryn L. Schueler, Jeea Choi, Matthew N. Bernstein, Daniel R. Turkewitz, Carlos Perez-Cervantes, Jason Spaeth, Roland Stein, Jeffery S. Tessem, Christina Kendziorski, Sündüz Keleş, Ivan P. Moskowitz, Mark P. Keller, and Alan D. Attie. Identification of direct transcriptional targets of nfatc2 that promote β cell proliferation. Journal of Clinical Investigation, Nov 2021. URL: https://doi.org/10.1172/jci144833, doi:10.1172/jci144833. This article has 26 citations and is from a highest quality peer-reviewed journal.
(kitamura2021isoformselectivenfatinhibitor pages 3-4): Noriko Kitamura and Osamu Kaminuma. Isoform-selective nfat inhibitor: potential usefulness and development. International Journal of Molecular Sciences, 22:2725, Mar 2021. URL: https://doi.org/10.3390/ijms22052725, doi:10.3390/ijms22052725. This article has 35 citations.
(kitamura2021isoformselectivenfatinhibitor pages 9-10): Noriko Kitamura and Osamu Kaminuma. Isoform-selective nfat inhibitor: potential usefulness and development. International Journal of Molecular Sciences, 22:2725, Mar 2021. URL: https://doi.org/10.3390/ijms22052725, doi:10.3390/ijms22052725. This article has 35 citations.
(zheng2024recentadvancesof pages 1-3): Hao Zheng, Yuexuan Liu, Yasi Deng, Yunzhe Li, Shiqi Liu, Yong Yang, Yun Qiu, Bin Li, Wenbing Sheng, Jinzhi Liu, Caiyun Peng, Wei Wang, and Huang-he Yu. Recent advances of nfatc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets. Molecular Medicine, Feb 2024. URL: https://doi.org/10.1186/s10020-024-00788-w, doi:10.1186/s10020-024-00788-w. This article has 72 citations and is from a peer-reviewed journal.
(zheng2024recentadvancesof pages 5-6): Hao Zheng, Yuexuan Liu, Yasi Deng, Yunzhe Li, Shiqi Liu, Yong Yang, Yun Qiu, Bin Li, Wenbing Sheng, Jinzhi Liu, Caiyun Peng, Wei Wang, and Huang-he Yu. Recent advances of nfatc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets. Molecular Medicine, Feb 2024. URL: https://doi.org/10.1186/s10020-024-00788-w, doi:10.1186/s10020-024-00788-w. This article has 72 citations and is from a peer-reviewed journal.
(samperebirlanga2026nonredundantfunctionsof pages 1-2): Salvador Sampere-Birlanga, Stefan Klein-Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, and Friederike Berberich-Siebelt. Non-redundant functions of nfatc1 in survival and nfatc2 in generation of exhausted cd8+ t cells. Frontiers in Immunology, Jul 2026. URL: https://doi.org/10.3389/fimmu.2026.1869029, doi:10.3389/fimmu.2026.1869029. This article has 1 citations and is from a peer-reviewed journal.
(wu2024newopportunitiesto pages 4-6): Bocheng Wu, Angela N. Koehler, and Peter M.K. Westcott. New opportunities to overcome t cell dysfunction: the role of transcription factors and how to target them. Trends in Biochemical Sciences, 49:1014-1029, Nov 2024. URL: https://doi.org/10.1016/j.tibs.2024.08.002, doi:10.1016/j.tibs.2024.08.002. This article has 10 citations and is from a domain leading peer-reviewed journal.
(thiel2021ca2+microdomainscalcineurin pages 17-18): Gerald Thiel, Tobias Schmidt, and Oliver G. Rössler. Ca2+ microdomains, calcineurin and the regulation of gene transcription. Cells, 10:875, Apr 2021. URL: https://doi.org/10.3390/cells10040875, doi:10.3390/cells10040875. This article has 77 citations.
(yang2025nfatc1incd4+ pages 1-2): Zuqin Yang, Susanne Krammer, Hannah Mitländer, Janina C. Grund, Sabine Zirlik, Stefan Wirtz, Manfred Rauh, Atefeh Sadeghi Shermeh, and Susetta Finotto. Nfatc1 in cd4+ t cells and cd11c+ dendritic cells drives th2-mediated eosinophilic inflammation in allergic asthma. Journal of Allergy and Clinical Immunology: Global, 4:100355, Feb 2025. URL: https://doi.org/10.1016/j.jacig.2024.100355, doi:10.1016/j.jacig.2024.100355. This article has 9 citations.
(chaudhry2024nfatsignalingis pages 7-9): M. Zeeshan Chaudhry, Lisa Borkner, Upasana Kulkarni, Friederike Berberich-Siebelt, and Luka Cicin-Sain. Nfat signaling is indispensable for persistent memory responses of mcmv-specific cd8+ t cells. PLOS Pathogens, 20:e1012025, Feb 2024. URL: https://doi.org/10.1371/journal.ppat.1012025, doi:10.1371/journal.ppat.1012025. This article has 10 citations and is from a highest quality peer-reviewed journal.
(samperebirlanga2026nonredundantfunctionsof pages 4-5): Salvador Sampere-Birlanga, Stefan Klein-Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, and Friederike Berberich-Siebelt. Non-redundant functions of nfatc1 in survival and nfatc2 in generation of exhausted cd8+ t cells. Frontiers in Immunology, Jul 2026. URL: https://doi.org/10.3389/fimmu.2026.1869029, doi:10.3389/fimmu.2026.1869029. This article has 1 citations and is from a peer-reviewed journal.
(samperebirlanga2026nonredundantfunctionsof pages 12-13): Salvador Sampere-Birlanga, Stefan Klein-Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, and Friederike Berberich-Siebelt. Non-redundant functions of nfatc1 in survival and nfatc2 in generation of exhausted cd8+ t cells. Frontiers in Immunology, Jul 2026. URL: https://doi.org/10.3389/fimmu.2026.1869029, doi:10.3389/fimmu.2026.1869029. This article has 1 citations and is from a peer-reviewed journal.
(samperebirlanga2026nonredundantfunctionsof pages 5-7): Salvador Sampere-Birlanga, Stefan Klein-Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, and Friederike Berberich-Siebelt. Non-redundant functions of nfatc1 in survival and nfatc2 in generation of exhausted cd8+ t cells. Frontiers in Immunology, Jul 2026. URL: https://doi.org/10.3389/fimmu.2026.1869029, doi:10.3389/fimmu.2026.1869029. This article has 1 citations and is from a peer-reviewed journal.
(samperebirlanga2026nonredundantfunctionsof pages 7-8): Salvador Sampere-Birlanga, Stefan Klein-Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, and Friederike Berberich-Siebelt. Non-redundant functions of nfatc1 in survival and nfatc2 in generation of exhausted cd8+ t cells. Frontiers in Immunology, Jul 2026. URL: https://doi.org/10.3389/fimmu.2026.1869029, doi:10.3389/fimmu.2026.1869029. This article has 1 citations and is from a peer-reviewed journal.
(kitamura2021isoformselectivenfatinhibitor pages 4-5): Noriko Kitamura and Osamu Kaminuma. Isoform-selective nfat inhibitor: potential usefulness and development. International Journal of Molecular Sciences, 22:2725, Mar 2021. URL: https://doi.org/10.3390/ijms22052725, doi:10.3390/ijms22052725. This article has 35 citations.
(kitamura2021isoformselectivenfatinhibitor pages 1-3): Noriko Kitamura and Osamu Kaminuma. Isoform-selective nfat inhibitor: potential usefulness and development. International Journal of Molecular Sciences, 22:2725, Mar 2021. URL: https://doi.org/10.3390/ijms22052725, doi:10.3390/ijms22052725. This article has 35 citations.
(kitamura2021isoformselectivenfatinhibitor pages 10-11): Noriko Kitamura and Osamu Kaminuma. Isoform-selective nfat inhibitor: potential usefulness and development. International Journal of Molecular Sciences, 22:2725, Mar 2021. URL: https://doi.org/10.3390/ijms22052725, doi:10.3390/ijms22052725. This article has 35 citations.
(patil2021chromatinindependentinterplayof pages 5-6): Shilpa Patil, Teresa Forster, Kristina Reutlinger, Waltraut Kopp, Lennart Versemann, Jessica Spitalieri, Jochen Gaedcke, Philipp Ströbel, Shiv K. Singh, Volker Ellenrieder, Albrecht Neesse, and Elisabeth Hessmann. Chromatin-independent interplay of nfatc1 and ezh2 in pancreatic cancer. Cells, 10:3463, Dec 2021. URL: https://doi.org/10.3390/cells10123463, doi:10.3390/cells10123463. This article has 9 citations.
(sato2024calcineurinnfatc1pathwayrepresses pages 11-12): Yuki Sato, Makoto Habara, Shunsuke Hanaki, Jafar Sharif, Haruki Tomiyasu, Yosei Miki, and Midori Shimada. Calcineurin/nfatc1 pathway represses cellular cytotoxicity by modulating histone h3 expression. Scientific Reports, Jun 2024. URL: https://doi.org/10.1038/s41598-024-65769-9, doi:10.1038/s41598-024-65769-9. This article has 4 citations and is from a peer-reviewed journal.
(patterson2021transcriptionalregulationby pages 8-9): Shaun D. Patterson, Xu Huang, Heather G. Jørgensen, and Alison M. Michie. Transcriptional regulation by the nfat family in acute myeloid leukaemia. Hemato, 2:556-571, Aug 2021. URL: https://doi.org/10.3390/hemato2030035, doi:10.3390/hemato2030035. This article has 10 citations.
(samperebirlanga2026nonredundantfunctionsof pages 13-15): Salvador Sampere-Birlanga, Stefan Klein-Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, and Friederike Berberich-Siebelt. Non-redundant functions of nfatc1 in survival and nfatc2 in generation of exhausted cd8+ t cells. Frontiers in Immunology, Jul 2026. URL: https://doi.org/10.3389/fimmu.2026.1869029, doi:10.3389/fimmu.2026.1869029. This article has 1 citations and is from a peer-reviewed journal.